Rockwell Medical Analyst Ratings
Rockwell Medical Analyst Ratings
羅克韋爾醫療分析師評級
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 09/28/2023 | 494.59% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 08/15/2023 | 494.59% | HC Wainwright & Co. | → $11 | Reiterates | Buy → Buy |
| 07/17/2023 | 494.59% | HC Wainwright & Co. | $9 → $11 | Maintains | Buy |
| 05/30/2023 | 386.49% | HC Wainwright & Co. | $7 → $9 | Maintains | Buy |
| 05/02/2023 | 278.38% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 04/04/2023 | 278.38% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/13/2023 | 278.38% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/08/2023 | 278.38% | HC Wainwright & Co. | $8 → $7 | Maintains | Buy |
| 08/30/2022 | 332.43% | HC Wainwright & Co. | $3 → $8 | Maintains | Buy |
| 01/18/2022 | 62.16% | HC Wainwright & Co. | $5 → $3 | Maintains | Buy |
| 09/07/2021 | 170.27% | HC Wainwright & Co. | $5.5 → $5 | Maintains | Buy |
| 02/08/2021 | 197.3% | HC Wainwright & Co. | $9 → $5.5 | Maintains | Buy |
| 04/07/2020 | 386.49% | HC Wainwright & Co. | $11 → $9 | Maintains | Buy |
| 11/12/2019 | 224.32% | Piper Sandler | $10 → $6 | Maintains | Overweight |
| 06/25/2019 | 494.59% | Cantor Fitzgerald | → $11 | Initiates Coverage On | → Overweight |
| 06/24/2019 | 440.54% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 10/19/2018 | 494.59% | IFS Securities | → $11 | Downgrades | Strong Buy → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
|---|---|---|---|---|---|
| 09/28/2023 | 494.59% | HC Wainwright公司 | →$11 | 重申 | 購買→購買 |
| 2023年08月15日 | 494.59% | HC Wainwright公司 | →$11 | 重申 | 購買→購買 |
| 07/17/2023 | 494.59% | HC Wainwright公司 | $9→$11 | 維護 | 買 |
| 2023年05月30日 | 386.49% | HC Wainwright公司 | $7→$9 | 維護 | 買 |
| 05/02/2023 | 278.38% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 04/04/2023 | 278.38% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 02/13/2023 | 278.38% | HC Wainwright公司 | →$7 | 重申 | →購買 |
| 02/08/2023 | 278.38% | HC Wainwright公司 | $8→$7 | 維護 | 買 |
| 2022年08月30日 | 332.43% | HC Wainwright公司 | $3→$8 | 維護 | 買 |
| 01/18/2022 | 62.16% | HC Wainwright公司 | $5→$3 | 維護 | 買 |
| 09/07/2021 | 170.27% | HC Wainwright公司 | $5.5→$5 | 維護 | 買 |
| 02/08/2021 | 197.3% | HC Wainwright公司 | $9→$5.5 | 維護 | 買 |
| 04/07/2020 | 386.49% | HC Wainwright公司 | $11→$9 | 維護 | 買 |
| 2019年11月12日 | 224.32% | 派珀·桑德勒 | $10→$6 | 維護 | 超重 |
| 2019年06月25日 | 494.59% | 康託·菲茨傑拉德 | →$11 | 開始承保 | →超重 |
| 2019年06月24日 | 440.54% | 派珀·桑德勒 | →$10 | 開始承保 | →超重 |
| 2018年10月19日 | 494.59% | IFS證券 | →$11 | 評級下調 | 強勢買入→跑贏大盤 |
What is the target price for Rockwell Medical (RMTI)?
羅克韋爾醫療公司(RMTI)的目標價格是多少？
There is no price target for Rockwell Medical
羅克韋爾醫療公司沒有價格目標
What is the most recent analyst rating for Rockwell Medical (RMTI)?
羅克韋爾醫療公司(RMTI)最近的分析師評級是多少？
There is no analyst for Rockwell Medical
羅克韋爾醫療公司沒有分析師
When is the next analyst rating going to be posted or updated for Rockwell Medical (RMTI)?
羅克韋爾醫療公司(RMTI)的下一次分析師評級將於何時發佈或更新？
There is no next analyst rating for Rockwell Medical
羅克韋爾醫療公司沒有下一個分析師評級
Is the Analyst Rating Rockwell Medical (RMTI) correct?
分析師對羅克韋爾醫療公司(RMTI)的評級正確嗎？
There is no next analyst rating for Rockwell Medical
羅克韋爾醫療公司沒有下一個分析師評級